| Typicality: | 0.232 |
| Saliency: | 0.164 |
| extensively | 5 | degree |
| in healthy children | 3 | location |
| very | 2 | degree |
| vaccine → be studied → safe | 7 |
| vaccine → be → safe, similar trials | 3 |
| negative | neutral | positive |
| 0.127 | 0.250 | 0.622 |
| Raw frequency | 10 |
| Normalized frequency | 0.164 |
| Modifier score | 0.500 |
| Perplexity | 350.701 |